Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
123.50    0.00 (0.00%)
Bid:
122.00
Ask:
125.00
Spread: 3.00 (2.459%)
Market Cap: £41.18m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Additional Subscription and Total Voting Rights

6 Dec 2024 07:00

RNS Number : 0457P
Onward Opportunities Limited
06 December 2024
 

6 December 2024

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Additional Subscription and Total Voting Rights

 

Onward Opportunities Limited, the UK smaller company focussed investment company, is pleased to announce that, further to the announcement of 7.00 a.m. on 4 December 2024, in response to investor demand it has raised additional gross proceeds of an aggregate of approximately £0.27 million by way of an additional direct subscription with the Company for an aggregate of 228,768 new ordinary shares (the "Additional Subscription Shares") at a price of 119.75 pence per Additional Subscription Share.

 

Pursuant to the Additional Subscription, application has been made for all Subscription Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 9 December 2024 and the Subscription Shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares.

 

Total Voting Rights

 

On Admission, the Company will have a total of 23,979,754 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 23,979,754 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used but not otherwise defined in this announcement shall have the meanings set out in the Company's announcement of the Subscription at 7.00 a.m. on 4 December 2024.

 

FOR FURTHER ENQUIRIES:

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Camilla Hume / Dan Hodkinson / Hamish Waller (Corporate Finance)

Chris West / Charlie Combe (Sales and ECM)

 

Tel: +44 (0) 207 220 0500

Dowgate Capital Limited (Joint Broker)

Russell Cook / Nicholas Chambers

 

Tel: +44 (0)20 3903 7715

 

To find out more, please visit: www.onwardopportunities.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUPGMAPUPCUWQ
12
Date   Source Headline
4th Jun 202611:57 amRNSNet Asset Value(s)
2nd Jun 202612:26 pmRNSPublication of May 2026 Factsheet
1st Jun 202612:03 pmRNSNet Asset Value(s)
28th May 202612:12 pmRNSNet Asset Value(s)
21st May 202611:34 amRNSNet Asset Value(s)
14th May 202612:17 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20264:39 pmRNSPurchase of Shares by the Portfolio Manager
7th May 20263:51 pmRNSPublication of April 2026 Factsheet - Replacement
7th May 202612:44 pmRNSPublication of April 2026 Factsheet
7th May 202611:50 amRNSNet Asset Value(s)
1st May 202611:31 amRNSNet Asset Value(s)
1st May 20267:01 amRNSTotal Voting Rights
1st May 20267:00 amRNSIssue of Equity
30th Apr 202611:54 amRNSNet Asset Value(s)
24th Apr 20267:00 amRNSIssue of Equity
23rd Apr 202611:54 amRNSNet Asset Value(s)
21st Apr 20262:12 pmRNSHolding(s) in Company
21st Apr 202610:24 amRNSPublication of Q1 2026 Factsheet
20th Apr 20269:05 amRNSBlock Admission Application
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20261:10 pmRNSNet Asset Value(s)
16th Apr 20268:00 amRNSReadmission - Onward Opportunities Limited
16th Apr 20267:00 amRNSAdmission to Main Market and AIM Cancellation
15th Apr 20269:29 amRNSResult of AGM
14th Apr 20262:46 pmRNSPurchase of Shares by Portfolio Manager
13th Apr 202612:19 pmRNSPublication of a Prospectus
9th Apr 20265:30 pmRNSOnward Opportunities
1st Apr 20264:13 pmRNSNet Asset Value(s)
26th Mar 202611:25 amRNSUpdate re Main Market Listing and Notice of AGM
2nd Mar 20264:56 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSIntended Main Market Listing
2nd Mar 20267:00 amRNSAnnual Results
5th Feb 20268:39 amRNSChange of Adviser
2nd Feb 20264:45 pmRNSNet Asset Value(s)
21st Jan 20264:04 pmRNSHolding(s) in Company - Replacement
21st Jan 20269:52 amRNSHolding(s) in Company
20th Jan 202610:34 amRNSHolding(s) in Company
19th Jan 20267:00 amRNSAdditional Subscription and Total Voting Rights
12th Jan 20267:00 amRNSIssue of Equity
12th Jan 20267:00 amRNSFull-Year Update
6th Jan 202612:00 pmRNSPublication of Q4 2025 Factsheet
2nd Jan 20264:05 pmRNSNet Asset Value(s)
31st Dec 202512:14 pmRNSHolding(s) in Company
31st Dec 202512:14 pmRNSHolding(s) in Company
4th Dec 20251:21 pmRNSDirector/PDMR Shareholding
1st Dec 20254:04 pmRNSNet Asset Value(s)
25th Nov 202511:34 amRNSHolding(s) in Company
19th Nov 20257:00 amRNSAdditional Subscription and Total Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.